Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02676193 · ClinicalTrials.gov registry record · NA
Effect of Packaging on Smoking Perceptions and Behavior
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 359
- Enrollment target
NCT02676193: Completed NA study, sponsored by University of California, San Diego.
NCT02676193 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 359 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02676193, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 359 participants
- Enrollment target
Study Summary
The investigators are addressing two critical areas identified by the FDA: the impact of cigarette packaging and labeling on consumer perceptions and on smoking behavior; and the effectiveness of graphic warning labels on communicating risk of tobacco products. In a randomized controlled trial (RCT), investigators will enroll committed smokers who have no intention of quitting in the next 6-months. The three study arms will be: a) a blank pack with all marketing materials removed (PP); b) The Australian graphic warning images (Australian model-AM); or c) a standard pack with all marketing materials unaltered (ST). The study includes a three month purchasing intervention and continued follow-up through 12 months. Throughout the study interactive text messaging assessments will be used to measure acute and persistent impact of labeling and marketing on perceptions of tobacco products, subjective effects of consumption, awareness of tobacco-related harms, tobacco use behavior, and quitting motivation. At three separate time points, participants will: a) complete a web-based questionnaire b) provide a saliva sample for cotinine analysis. The rigorous design and extensive objective measurements are significant innovations on the currently published research in this field and should lead to significant advances in tobacco regulatory science.
Primary Outcome
Changes in perceptions of risk from tobacco use and appeal of tobacco packs
Interventions
- BEHAVIORAL Effect of Packaging on Smoking Perceptions and Behavior
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 359 participants |
| Start Date | 2016-02 |
| Est. Completion | 2022-09 |
| Phase | NA |
What the finished NCT02676193 record still lists
NCT02676193 is an interventional study that assigns participants to a tested intervention. The registered 359 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which Effect of Packaging on Smoking Perceptions and Behavior is the first listed.
NCT02676193 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02676193 about?
NCT02676193 is a clinical study titled "Effect of Packaging on Smoking Perceptions and Behavior". The investigators are addressing two critical areas identified by the FDA: the impact of cigarette packaging and labeling on consumer perceptions and on smoking behavior; and the effectiveness of graphic warning labels on communicating risk of tobacco products. In a randomized controlled trial (RCT)...
What is the current status of trial NCT02676193?
This trial is currently completed. It is a NA study. The enrollment target is 359 participants. The study started on 2016-02. Estimated completion is 2022-09.
What interventions are being tested in trial NCT02676193?
The interventions under investigation include: Effect of Packaging on Smoking Perceptions and Behavior (BEHAVIORAL).
Who is sponsoring clinical trial NCT02676193?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02676193's enrollment target sits among peer trials
359 288th of 2000 higher than 1,713 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05118789 · 359 participants · Phase 1
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia